FAM
SAGE icon

Fred Alger Management’s Sage Therapeutics SAGE Stock Holding History

Fred Alger Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-104,851
Closed -$5.96M – 554
2021
Q2 		$5.96M Buy
104,851
+83,037
+381% +$5.87M 0.01% 282
2021
Q1 		$1.63M Sell
21,814
-20,016
-48% -$1.64M ﹤0.01% 354
2020
Q4 		$3.62M Sell
41,830
-105,738
-72% -$7.79M 0.01% 296
2020
Q3 		$9.02M Buy
+147,568
New +$7.48M 0.03% 211
2020
Q2 		– Sell
-12,000
Closed -$345K – 585
2020
Q1 		$345K Sell
12,000
-3,000
-20% -$174K ﹤0.01% 374
2019
Q4 		$1.08M Buy
15,000
+7,500
+100% +$923K ﹤0.01% 332
2019
Q3 		$1.05M Buy
7,500
+500
+7% +$83.6K ﹤0.01% 328
2019
Q2 		$1.28M Buy
7,000
+1,000
+17% +$171K ﹤0.01% 322
2019
Q1 		$954K Buy
+6,000
New +$869K ﹤0.01% 338
2018
Q4 		– Sell
-19,989
Closed -$2.82M – 566
2018
Q3 		$2.82M Sell
19,989
-3,471
-15% -$536K 0.01% 264
2018
Q2 		$3.67M Buy
23,460
+4,276
+22% +$671K 0.02% 245
2018
Q1 		$3.09M Buy
19,184
+12,684
+195% +$2.15M 0.01% 263
2017
Q4 		$1.07M Sell
6,500
-3,509
-35% -$340K ﹤0.01% 333
2017
Q3 		$624K Buy
10,009
+1,000
+11% +$78.5K ﹤0.01% 347
2017
Q2 		$717K Buy
9,009
+1,009
+13% +$72.9K ﹤0.01% 350
2017
Q1 		$569K Buy
+8,000
New +$469K ﹤0.01% 356

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fred Alger Management's SAGE Position: Q3 2021 in Review

Fred Alger Management sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 104,851 shares — an estimated $5.96M sold.

Fred Alger Management first reported a position in SAGE in Q1 2017 and held it in 16 quarters. The position peaked at $9.02M in Q3 2020. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Fred Alger Management reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Fred Alger Management sold 104,851 Sage Therapeutics shares in Q3 2021, an estimated $5.96M.
  • Fred Alger Management first reported a position in Sage Therapeutics in Q1 2017 and held it in 16 quarters.
  • Fred Alger Management's Sage Therapeutics position peaked at $9.02M in Q3 2020.
  • 226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Fred Alger Management's 13F filing for Q3 2021, filed 15 Nov 2021.